IP Library Granted Patent US 9,638,706
Granted Patent B2
US 9,638,706 · App. 14/232,073 · Granted May 2, 2017

Standard solution for use in analysis of amino acid in plasma

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,638,706
App. No.
14/232,073
Granted
May 2, 2017
Kind
B2
Abstract

An external standard solution for use in the analysis of amino acid in plasma, containing, (1) at least one amino acid selected from the following components A, at a concentration of 0.0007 M to 0.49 M, and (2) (i) at least one amino acid selected from the following components B, at a concentration of 0.2 to 0.9 times of the lowest-concentration amino acid among the amino acids selected from components A, (ii) at least one amino acid selected from the following components C, at a concentration of 0.1 to 0.4 times of the lowest-concentration amino acid among amino acids selected from the components A, or (iii) at least one amino acid selected from the following components D, at a concentration of 0.05 to 0.2 times of the lowest-concentration amino acid among amino acids selected from the components A; [Components A] valine, glycine, alanine and glutamine [Components B] serine, proline, threonine, taurine, leucine, isoleucine, lysine, histidine, phenylalanine and tyrosine [Components C] asparagine, ornithine, arginine and tryptophan [Components D] glutamic acid, methionine, citrulline and cystine.

Claims (38)

1. An external standard solution comprising:

(1) water or buffer,

(2) at least one amino acid selected from the following Components A, at a concentration of 0.0007 M to 0.49 M per amino acid; and

(3) at least one of (i), (ii), or (iii):

(i) at least one amino acid selected from the following Components B, wherein each amino acid selected from Components B has a concentration of 0.2 to 0.9 times that of the lowest-concentration amino acid among amino acids selected from Components A,

(ii) at least one amino acid selected from the following Components C, wherein each amino acid selected from Components C has a concentration of 0.1 to 0.4 times that of the lowest-concentration amino acid among amino acids selected from Components A, and when the external standard solution includes an amino acid selected from Components B, has a concentration of less than 1 times that of the lowest-concentration amino acid among amino acids selected from Components B, or

(iii) at least one amino acid selected from the following Components D, wherein each amino acid selected from Components D has a concentration of 0.05 to 0.2 times that of the lowest-concentration amino acid among amino acids selected from Components A, and when the external standard solution includes an amino acid selected from Components B, has a concentration of less than 1 times that of the lowest-concentration amino acid among amino acids selected from Components B, and when the external standard solution includes Components C, has a concentration of less than 1 times that of the lowest-concentration amino acid among amino acids selected from Components C;

wherein the Components A are valine, glycine, alanine, and glutamine;

wherein the Components B are serine, proline, threonine, taurine, leucine, isoleucine, lysine, histidine, phenylalanine, and tyrosine;

wherein the Components C are asparagine, ornithine, arginine, and tryptophan; and

wherein the Components D are glutamic acid, methionine, citrulline, and cystine.

2. The external standard solution according to claim 1 , wherein the external standard solution contains (1) at least one amino acid selected from Components A, at 0.0007 M to 0.49 M per amino acid, and (2) at least one amino acid selected from Components B, wherein each amino acid selected from Components B has a concentration of 0.2 to 0.9 times that of the lowest-concentration amino acid among amino acids selected from Components A.

3. The external standard solution according to claim 2 , wherein the external standard solution further contains at least one amino acid selected from Components C, wherein each amino acid selected from Components C has a concentration of 0.1 to 0.4 times that of the lowest-concentration amino acid among amino acids selected from Components A, and a concentration of less than 1 times that of the lowest-concentration amino acid among amino acids selected from Components B.

4. The external standard solution according to claim 3 , wherein the external standard solution further contains at least one amino acid selected from Components D, wherein each amino acid selected from Components D has a concentration of 0.05 to 0.2 times that of the lowest-concentration amino acid among amino acids selected from Components A, has a concentration of less than 1 times that of the lowest-concentration amino acid among amino acids selected from Components B, and has a concentration of less than 1 times that of the lowest-concentration amino acid among amino acids selected from the Components C.

5. An external standard substance obtained by lyophilizing the external standard solution according to claim 1 .

6. A method for analyzing amino acids in plasma, the method comprising (i) preparing an external standard solution according to claim 1 ; (ii) analyzing the amino acids in a plasma sample by separation analysis; (iii) preparing a calibration curve with the external standard solution using said separation analysis; and (iv) determining the concentration of amino acids in the plasma sample by applying the calibration curve to the results obtained by the separation analysis of the plasma sample.

7. The method of claim 6 , wherein the separation analysis is conducted by liquid chromatography-mass spectrometry.

8. An external standard solution, comprising water or buffer and valine and at least one of leucine, isoleucine, phenylalanine, tyrosine, histidine, tryptophan, and citrulline;

wherein valine has a concentration of 0.0003 M to 0.49 M;

wherein if leucine is included in the external standard solution, its concentration is 0.1 to less than 1.0 times the concentration of valine;

wherein if isoleucine is included in the external standard solution, its concentration is 0.05 to 0.7 times the concentration of valine;

wherein if phenylalanine is included in the external standard solution, its concentration is 0.1 to 0.6 times the concentration of valine;

wherein if tyrosine is included in the external standard solution, its concentration is 0.1 to 0.7 times the concentration of valine;

wherein if histidine is included in the external standard solution, its concentration is 0.1 to 0.8 times the concentration of valine;

wherein if tryptophan is included in the external standard solution, its concentration is 0.1 to 0.6 times the concentration of valine, and when leucine, isoleucine, phenylalanine, tyrosine, or histidine is included, the concentration of tryptophan is less than 1 times that of the lowest-concentration amino acid of leucine, isoleucine, phenylalanine, tyrosine, or histidine; and

wherein if citrulline is included in the external standard solution, its concentration is 0.01 to 0.3 times the concentration of valine, and when leucine, isoleucine, phenylalanine, tyrosine, histidine, or tryptophan is included, the concentration of citrulline is less than 1 times that of the lowest-concentration amino acid of leucine, isoleucine, phenylalanine, tyrosine, histidine, or tryptophan.

9. The external standard solution according to claim 8 , comprising valine and at least one of leucine and isoleucine;

wherein valine has a concentration of 0.0003 M to 0.49 M;

wherein if leucine is included in the external standard solution, its concentration is 0.1 to less than 1.0 times the concentration of valine; and

wherein if isoleucine is included in the external standard solution, its concentration is 0.05 to 0.7 times the concentration of valine.

10. The external standard solution according to claim 9 , further comprising at least one of phenylalanine and tyrosine;

wherein if phenylalanine is included in the external standard solution, its concentration is 0.1 to 0.6 times the concentration of valine; and

wherein if tyrosine is included in the external standard solution, its concentration is 0.1 to 0.7 times the concentration of valine.

11. The external standard solution according to claim 10 , further comprising at least one of histidine and tryptophan;

wherein if histidine is included in the external standard solution, its concentration is 0.1 to 0.8 times the concentration of valine; and

wherein if tryptophan is included in the external standard solution, its concentration is 0.1 to 0.6 times the concentration of valine, and when leucine, isoleucine, phenylalanine, tyrosine, or histidine is included, the concentration of tryptophan is less than 1 times that of the lowest-concentration amino acid of leucine, isoleucine, phenylalanine, tyrosine, or histidine.

12. The external standard solution according to claim 11 , further comprising citrulline;

wherein the concentration of citrulline is 0.01 to 0.3 times the concentration of valine, and when leucine, isoleucine, phenylalanine, tyrosine, histidine, or tryptophan is included in the external standard solution, the concentration of citrulline is less than 1 times that of the lowest-concentration amino acid of leucine, isoleucine, phenylalanine, tyrosine, histidine, or tryptophan.

Assignments (2)
CHANGE OF NAME Recorded Jun 7, 2018
From: WAKO PURE CHEMICAL INDUSTRIES, LTD.
To: FUJIFILM WAKO PURE CHEMICAL CORPORATION
Reel/Frame 047816/0612 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2014
From: HAYAKAWA, MASAKO; SHIMBO, KAZUTAKA; YOSHIDA, HIROO
To: WAKO PURE CHEMICAL INDUSTRIES, LTD.; AJINOMOTO CO., INC.
Reel/Frame 032849/0368 →